Giuseppe Cancian

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Validation and Repeatability of Differential Light Sensitivity Measurements with the Novel MAIA Microperimetry Device.

Validation and Repeatability of Differential Light Sensitivity Measurements with the Novel MAIA Microperimetry Device.

Journal: Ophthalmology science
Published: January 25, 2025

DRUSEN VOLUME AS CLINICAL OUTCOME MEASURE IN SUBJECTS WITH MALATTIA LEVENTINESE.

DRUSEN VOLUME AS CLINICAL OUTCOME MEASURE IN SUBJECTS WITH MALATTIA LEVENTINESE.

Journal: Retina (Philadelphia, Pa.)
Published: January 22, 2025

Ocular alterations in pseudoxanthoma elasticum : The eye as a window to diagnosing a systemic disease

Ocular alterations in pseudoxanthoma elasticum : The eye as a window to diagnosing a systemic disease

Journal: Die Ophthalmologie
Published: January 14, 2025

Autosomal Dominant RP1 c.2613dupA (p.Arg872Thrfs*2) Variant Retinitis Pigmentosa Shows Linear Loss of the Ellipsoid Zone over Time with Highly Variable Phenotype.

Autosomal Dominant RP1 c.2613dupA (p.Arg872Thrfs*2) Variant Retinitis Pigmentosa Shows Linear Loss of the Ellipsoid Zone over Time with Highly Variable Phenotype.

Journal: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
Published: September 12, 2024

Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study.

Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study.

Journal: International journal of retina and vitreous
Published: August 05, 2024

One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration.

One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration.

Journal: Ophthalmology and therapy
Published: July 29, 2024

Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study.

Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: August 25, 2023

Trans-Scleral Plugs Fixated FIL SSF IOL: A Review of the Literature and Comparison with Other Secondary IOL Implants.

Trans-Scleral Plugs Fixated FIL SSF IOL: A Review of the Literature and Comparison with Other Secondary IOL Implants.

Journal: Journal of clinical medicine
Published: December 18, 2022

Assessment of the specificity of corvis biomechanical index-laser vision correction (CBI-LVC) in stable corneas after phototherapeutic keratectomy.

Assessment of the specificity of corvis biomechanical index-laser vision correction (CBI-LVC) in stable corneas after phototherapeutic keratectomy.

Journal: International ophthalmology
Published: September 15, 2022

Curcumin in Retinal Diseases: A Comprehensive Review from Bench to Bedside.

Curcumin in Retinal Diseases: A Comprehensive Review from Bench to Bedside.

Journal: International journal of molecular sciences
Published: January 21, 2022

Outcomes of Abrupt Switch to Bevacizumab of Patients Undergoing Aflibercept Intravitreal Injections for Neovascular Age-Related Macular Degeneration in a Tertiary Center in Lombardy, Italy: A Real-Life Retrospective Analysis.

Outcomes of Abrupt Switch to Bevacizumab of Patients Undergoing Aflibercept Intravitreal Injections for Neovascular Age-Related Macular Degeneration in a Tertiary Center in Lombardy, Italy: A Real-Life Retrospective Analysis.

Journal: Journal of ophthalmology
Published: April 28, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026